<DOC>
	<DOCNO>NCT02831387</DOCNO>
	<brief_summary>The purpose study evaluate effect treatment 0.017 % P-321 Dry Eye Symptoms .</brief_summary>
	<brief_title>Evaluation P-321 Ophthalmic Solution Compared Placebo Subjects With Dry Eye Disease</brief_title>
	<detailed_description>This multi-center , randomize , double-masked , placebo-controlled , parallel group Phase 2b trial design evaluate symptom sign subject mild moderate dry eye disease . Eligible patient , treat placebo 2-week placebo run-in period . Subjects randomly assign double-masked , 1:1 ratio either 0.017 % P-321 Ophthalmic Solution placebo TID 28 day . This study design evaluate change symptom . Safety assess throughout study adverse event .</detailed_description>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<mesh_term>Eye Diseases</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>1 . Provide write informed consent 2 . Male female subject age 18 80 year , inclusive 3 . Have history dry eye disease ( DED ) eye 4 . Be stable regimen need medication 5 . Have BCVA +0.7 well assess Early Treatment Diabetic Retinopathy Study ( ETDRS ) 6 . Have report symptom 7 . Have Schirmer score without anesthesia &gt; 1 &lt; 10 mm 5 minute eye stain conjunctival corneal area eye . 8 . Have normal lid anatomy 1 . Have undergone refractive eye surgery 2 . Have undergone previous eyelid surgery either eye 3 . Have lid irregularity deformities 4 . Have history glaucoma , history elevate lOP within past year , lOP either eye &gt; 25 mmHg Screening Visit ( Visit 1 ) 5 . Have clinically significant , uncontrolled , unstable medical surgical condition could affect ability participate 6 . Have permanent punctal plug , punctal occlusion , history nasolacrimal duct obstruction . Removable punctal plug allow use regularly least 60 day prior screen visit . However , plug come study must promptly replace . 7 . Have clinical finding severe Meibomian Gland Dysfunction ( MGD ) 8 . Are pregnant breast feed 9 . Use investigational product device within 28 day prior Screening Visit study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>